How is cancer treatment response monitored in dogs?

Monitoring is a series of comparisons

Your dog’s oncology team compares findings over time: how your dog feels, examination results and tests chosen for their particular cancer. There is no single follow-up schedule or blood test that suits every dog. AAHA: Post-treatment monitoring and follow-up care, 2026.

What the team may follow

Depending on the disease and treatment, follow-up may include checking measurable tumours or lymph nodes, bloodwork, imaging and treatment side effects. Changes must be interpreted in context: a new symptom can reflect the cancer, a treatment effect or another health problem. Your veterinary team decides which investigation will answer the clinical question. AAHA follow-up guidance.

Keep a simple record of changes in appetite, activity and comfort, with dates. Ask your team which changes warrant a call and how to contact them between appointments.

Remission does not necessarily mean cure

In canine lymphoma, remission describes a reduction or disappearance of detectable signs of cancer after treatment. Disease can return, so follow-up remains important even when a dog is doing well. Prognosis and treatment options vary; population averages cannot predict an individual dog’s course. Cornell University: Oncology medical conditions.

What about cfDNA monitoring?

Cell-free DNA research explores whether molecular changes in blood can add information during treatment and follow-up. Canos’s September 2026 benchmark analysed existing datasets; it was not a prospective trial showing that using the test improves outcomes. The preprint is not peer reviewed. Canos research, version 1.

Canos OncoTrack is an exploratory trial for dogs diagnosed with cancer. Its results must be considered alongside veterinary assessment. Ask about the trial.